Diverse mechanisms by which ZFPM2-AS1 modulates cancer progression have been well revealed, including stabilizing MIF in gastric cancer [17] and sponging miR-18b-5p to regulate VMA21 expression in lung adenocarcinoma [18]. The gene discussed is MIF; the disease is lung adenocarcinoma.